Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Weighted Average and Diluted): 2018-2024

Historic EPS (Weighted Average and Diluted) for Organogenesis Holdings (ORGO) over the last 7 years, with Dec 2024 value amounting to -$0.01.

  • Organogenesis Holdings' EPS (Weighted Average and Diluted) rose 22.22% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.12, marking a year-over-year decrease of 86.69%. This contributed to the annual value of -$0.01 for FY2024, which is 125.00% down from last year.
  • As of FY2024, Organogenesis Holdings' EPS (Weighted Average and Diluted) stood at -$0.01, which was down 125.00% from $0.04 recorded in FY2023.
  • Organogenesis Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.70 during FY2021, with a 5-year trough of -$0.01 in FY2024.
  • Over the past 3 years, Organogenesis Holdings' median EPS (Weighted Average and Diluted) value was $0.04 (recorded in 2023), while the average stood at $0.05.
  • As far as peak fluctuations go, Organogenesis Holdings' EPS (Weighted Average and Diluted) skyrocketed by 366.67% in 2021, and later crashed by 125.00% in 2024.
  • Organogenesis Holdings' EPS (Weighted Average and Diluted) (Yearly) stood at $0.15 in 2020, then skyrocketed by 366.67% to $0.70 in 2021, then tumbled by 82.86% to $0.12 in 2022, then crashed by 66.67% to $0.04 in 2023, then crashed by 125.00% to -$0.01 in 2024.